196 related articles for article (PubMed ID: 35185784)
1. The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency.
Kalafat E; Dizdar M; Turkgeldi E; Yildiz S; Keles I; Ata B
Front Endocrinol (Lausanne); 2021; 12():797227. PubMed ID: 35185784
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
[TBL] [Abstract][Full Text] [Related]
3. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
[TBL] [Abstract][Full Text] [Related]
4. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fixed and flexible progestin-primed ovarian stimulation protocols to prevent premature luteinization in patients with diminished ovarian reserve.
Doğan Durdağ G; Çağlar Aytaç P; Alkaş Yağınç D; Yetkinel S; Çok T; Şimşek E
Arch Gynecol Obstet; 2023 Aug; 308(2):579-586. PubMed ID: 37179254
[TBL] [Abstract][Full Text] [Related]
6. Should the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?
Ata B; Cakar A; Türkgeldi E; Yildiz S; Keles İ; Kalafat E
Reprod Biomed Online; 2024 Feb; 48(2):103626. PubMed ID: 38160486
[TBL] [Abstract][Full Text] [Related]
7. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
9. Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.
Lin Y; Chen Q; Zhu J; Teng Y; Huang X; Chen X
Drug Des Devel Ther; 2021; 15():5087-5097. PubMed ID: 34992345
[TBL] [Abstract][Full Text] [Related]
10. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
[TBL] [Abstract][Full Text] [Related]
11. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve.
Turkgeldi E; Yildiz S; Cekic SG; Shakerian B; Keles I; Ata B
Hum Fertil (Camb); 2022 Apr; 25(2):306-312. PubMed ID: 32672129
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
Zhang S; Yin Y; Li Q; Zhang C
Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of progestin-primed ovarian stimulation (PPOS) versus minimal stimulation in women of advanced maternal age with poor ovarian response under the Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) criteria.
Zhao S; Wang C
Ann Palliat Med; 2023 Jan; 12(1):133-140. PubMed ID: 36747387
[TBL] [Abstract][Full Text] [Related]
15. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
[TBL] [Abstract][Full Text] [Related]
16. Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Huang J; Xie Q; Lin J; Lu X; Zhu J; Gao H; Cai R; Kuang Y
Drug Des Devel Ther; 2019; 13():4461-4470. PubMed ID: 32099323
[TBL] [Abstract][Full Text] [Related]
17. Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study.
Hendrickx S; De Vos M; De Munck N; Mackens S; Ruttens S; Tournaye H; Blockeel C
Reprod Biomed Online; 2024 May; 48(5):103732. PubMed ID: 38458058
[TBL] [Abstract][Full Text] [Related]
18. The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study.
Zhang Y; Li H; Zhu S; Jiang S; Zhao W; Wang X; Tian L; Zhao G; He N; Diao H; Cao H; Zhang C
Front Endocrinol (Lausanne); 2023; 14():1295787. PubMed ID: 38155955
[TBL] [Abstract][Full Text] [Related]
19. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]